These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 19581577)
1. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia. Ahmad ST; Sweeney ST; Lee JA; Sweeney NT; Gao FB Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12168-73. PubMed ID: 19581577 [TBL] [Abstract][Full Text] [Related]
2. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila. Lu Y; West RJH; Pons M; Sweeney ST; Gao FB Sci Rep; 2020 Aug; 10(1):14221. PubMed ID: 32848189 [TBL] [Abstract][Full Text] [Related]
3. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila. Cheruiyot A; Lee JA; Gao FB; Ahmad ST FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394 [TBL] [Abstract][Full Text] [Related]
4. Molecular Genetics of Frontotemporal Dementia Elucidated by Vandal SE; Zheng X; Ahmad ST Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective activity of ursodeoxycholic acid in CHMP2B West RJH; Ugbode C; Fort-Aznar L; Sweeney ST Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000 [TBL] [Abstract][Full Text] [Related]
6. Serpin Facilitates Tumor-Suppressive Cell Competition by Blocking Toll-Mediated Yki Activation in Drosophila. Katsukawa M; Ohsawa S; Zhang L; Yan Y; Igaki T Curr Biol; 2018 Jun; 28(11):1756-1767.e6. PubMed ID: 29804808 [TBL] [Abstract][Full Text] [Related]
7. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
8. Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia, is required for autophagosome maturation. Lu Y; Zhang Z; Sun D; Sweeney ST; Gao FB Mol Cell; 2013 Oct; 52(2):264-71. PubMed ID: 24095276 [TBL] [Abstract][Full Text] [Related]
10. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia. West RJ; Lu Y; Marie B; Gao FB; Sweeney ST J Cell Biol; 2015 Mar; 208(7):931-47. PubMed ID: 25800055 [TBL] [Abstract][Full Text] [Related]
11. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias. Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997 [TBL] [Abstract][Full Text] [Related]
12. Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity. Wilson C; Kavaler J; Ahmad ST Dev Neurobiol; 2020 Mar; 80(3-4):85-97. PubMed ID: 31587468 [TBL] [Abstract][Full Text] [Related]
13. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3. Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250 [TBL] [Abstract][Full Text] [Related]
14. The role of CHMP2B in frontotemporal dementia. Urwin H; Ghazi-Noori S; Collinge J; Isaacs A Biochem Soc Trans; 2009 Feb; 37(Pt 1):208-12. PubMed ID: 19143633 [TBL] [Abstract][Full Text] [Related]
15. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia. Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215 [TBL] [Abstract][Full Text] [Related]
16. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655 [TBL] [Abstract][Full Text] [Related]
18. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491 [TBL] [Abstract][Full Text] [Related]
19. CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1. Deng X; Sun X; Yue W; Duan Y; Hu R; Zhang K; Ni J; Cui J; Wang Q; Chen Y; Li A; Fang Y J Cell Biol; 2022 Jan; 221(1):. PubMed ID: 34726688 [TBL] [Abstract][Full Text] [Related]